Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Oct 13, 2014
UCB's core antibody discovery platform combines high-throughput B cell culture screening and the identification and isolation of single, antigen specific IgG-secreting B cells through a proprietary technique known as ‘fluorescent foci' method. Using state of the art automation to facilitate screening, extremely efficient interrogation of the natural antibody repertoire is made possible.